How to Get Viagra in Maryland

What Sildenafil (Viagra) Is and How It Works

Sildenafil is a phosphodiesterase type-5 (PDE5) inhibitor approved by the FDA in March 1998 for the treatment of erectile dysfunction (ED) in adult males. It works by blocking PDE5 in penile smooth muscle, which prevents degradation of cyclic GMP, sustains vasodilation, and allows an erection in response to sexual stimulation.

The Clinical Evidence Behind Sildenafil

Goldstein et al. Published the landmark sildenafil trial in the New England Journal of Medicine in 1998 (N=532). Successful intercourse was reported by 69% of sildenafil-treated men versus 22% of placebo-treated men across all ED etiologies 1. That trial enrolled men with organic, psychogenic, and mixed ED, making the findings broadly applicable.

A 2013 Cochrane review of PDE5 inhibitors (k=234 trials, N=46,721) confirmed that sildenafil improves the International Index of Erectile Function (IIEF) erectile function domain score by a mean of 6.6 points over placebo 2.

FDA-Approved Dosing

The FDA label specifies 50 mg as the recommended starting dose, titrated to 25 mg if tolerability is a concern or up to 100 mg based on efficacy 3. One dose per 24-hour period is the maximum. The drug reaches peak plasma concentration in 30 to 60 minutes under fasted conditions; a high-fat meal delays absorption by approximately 60 minutes and reduces peak concentration by 29% 3.

Maryland Prescribing Law: Who Can Write the Prescription

In Maryland, sildenafil requires a valid prescription from a licensed prescriber. Three categories of clinicians hold prescriptive authority for this medication under Maryland Health Occupations Article.

Physicians (MD and DO)

Maryland-licensed MDs and DOs may prescribe sildenafil without restriction beyond the federal scheduling rules. ED falls squarely within primary care, urology, and endocrinology scopes of practice.

Nurse Practitioners and Physician Assistants

Maryland nurse practitioners (NPs) with a current Nurse Practitioner Certification may prescribe independently under Maryland Code, Health Occupations Article §8-601. Physician assistants (PAs) in Maryland may also prescribe sildenafil, subject to a written agreement with a supervising physician as required by Maryland Code, Health Occupations Article §15-302. Both NPs and PAs routinely prescribe ED medications through telehealth platforms operating in the state.

Telehealth Prescribing Authority

Maryland's telehealth framework, codified in Maryland Code Health-General Article §15-141.2, allows synchronous audio-video encounters to serve as the qualifying visit for a new prescription. The Maryland Board of Physicians does not require a prior in-person visit before a telehealth provider may prescribe sildenafil, provided a good-faith clinical evaluation is completed. The American Telemedicine Association notes that state telehealth parity laws, now in place across 43 states including Maryland, have materially expanded access to sexual health prescriptions 4.

How to Get a Sildenafil Prescription in Maryland: Step-by-Step

Getting a prescription follows a predictable sequence regardless of whether you choose in-person or telehealth.

Step 1: Choose Your Visit Type

In-person: Book with a primary care physician, urologist, or men's health clinic. Most practices can see new patients for ED within one to two weeks. Same-day urgent care visits are also an option at many Maryland walk-in clinics.

Telehealth: Maryland-licensed telehealth platforms (including HealthRX) complete a synchronous video or asynchronous questionnaire-based evaluation. Most issue a prescription decision within two to four hours of intake form submission.

Step 2: Complete the Clinical Evaluation

The clinician will gather a focused sexual health history, review comorbidities (diabetes, hypertension, cardiovascular disease), and screen for nitrate use. The Massachusetts Male Aging Study found that ED affects approximately 52% of men aged 40 to 70, with prevalence rising sharply with age and metabolic disease burden 5. That epidemiology means most Maryland clinicians are well-practiced in this evaluation.

Step 3: Laboratory Testing

Routine baseline labs before sildenafil are not universally mandated by FDA labeling but are recommended by the American Urological Association (AUA) 2018 ED guidelines 6 for men with uncharacterized ED. Standard labs include:

• Fasting glucose or HbA1c (screens for undiagnosed diabetes)
• Lipid panel (cardiovascular risk stratification)
• Total testosterone (morning specimen; low T independently worsens ED) 7
• TSH if thyroid disease is clinically suspected
• PSA if age or risk warrants prostate screening per shared decision-making

A telehealth prescriber may accept recent labs (within 6 to 12 months) from your primary care record, or order labs through a statewide draw-site network before finalizing the prescription.

Step 4: Receive the E-Prescription

Maryland accepts electronic prescriptions for non-controlled substances. Sildenafil is not a federally controlled substance (DEA schedules I, V); it is unscheduled at the federal level. Maryland does not impose a state-level schedule on sildenafil. The prescriber transmits an e-prescription directly to your chosen pharmacy.

Step 5: Fill at a Maryland Pharmacy or Accept Delivery

Retail pharmacies across Maryland stock generic sildenafil. Mail-order and telehealth-affiliated pharmacies ship to Maryland residential addresses, typically within one to three business days.

Costs and Insurance Coverage in Maryland

Brand vs. Generic Pricing

Brand-name Viagra 50 mg carries a retail price near $70, $80 per tablet at Maryland pharmacies without insurance. Generic sildenafil 50 mg tablets typically cost $1, $4 each through GoodRx-affiliated pricing or discount programs, representing a reduction of more than 95% from peak brand pricing.

Private Insurance

Most Maryland commercial plans (including those sold on the Maryland Health Connection ACA marketplace) exclude ED medications from standard formularies. Some employer-sponsored plans cover sildenafil when prescribed off-label for pulmonary arterial hypertension (Revatio indication) 8, but the ED indication is typically excluded per plan design.

Maryland Medicaid (HealthChoice)

Maryland Medicaid covers sildenafil for erectile dysfunction with prior authorization (PA). The PA process requires the prescriber to document:

1. Confirmed diagnosis of erectile dysfunction (ICD-10 N52.x)
2. Medical necessity (relevant comorbidity such as diabetes mellitus, post-prostatectomy status, or spinal cord injury)
3. Absence of absolute contraindications (nitrate use, severe hepatic failure)
4. Failure or contraindication to a lifestyle-based first-line approach when clinically appropriate

The AUA 2018 guideline states: "Clinicians should discuss the impact of lifestyle factors and modification as part of the treatment plan for men with ED" 6. Maryland Medicaid reviewers look for documentation of this discussion in the clinical note supporting PA.

HealthRX Maryland Prior Authorization Checklist: Our clinical team has distilled the Maryland Medicaid PA requirements into a five-point documentation framework (diagnosis coding, comorbidity linkage, contraindication screening, lifestyle counseling notation, and prescriber attestation) that reduces first-round PA denials. Your assigned care coordinator completes this at no added cost when you use HealthRX.

Telehealth Providers in Maryland Prescribing Sildenafil

Telehealth is now the fastest and most commonly used pathway for Maryland men seeking sildenafil. A 2022 study in the Journal of Sexual Medicine found that 61% of new ED prescriptions issued during a 24-month post-pandemic window originated from telehealth encounters, compared with 19% pre-pandemic 9.

What a Compliant Maryland Telehealth Visit Includes

Maryland law and standard of care require that the telehealth prescriber:

• Establishes a clinician-patient relationship during the encounter
• Collects a complete medication list to screen for nitrate interactions
• Asks about cardiovascular symptoms (chest pain on exertion, syncope)
• Documents blood pressure (patient-reported home reading is acceptable for stable patients)
• Provides follow-up instructions

Typical Timeline with HealthRX

| Step | Estimated Time | |---|---| | Online intake form | 10 minutes | | Clinician review and decision | 2 to 4 hours (business hours) | | E-prescription sent to pharmacy | Same day in most cases | | Pharmacy dispensing (retail) | Same day or next day | | Mail delivery from affiliated pharmacy | 1 to 3 business days |

Asynchronous vs. Synchronous Visits

Maryland regulations permit asynchronous ("store-and-forward") telehealth for established patients renewing a prescription. New patients generally require a synchronous video or phone visit to satisfy the good-faith evaluation standard upheld by the Maryland Board of Physicians.

503A Compounding Pharmacies in Maryland

What 503A Means

A 503A pharmacy is a state-licensed compounding pharmacy operating under Section 503A of the federal Food, Drug, and Cosmetic Act. These pharmacies may compound sildenafil into non-commercially available forms: different strengths, alternative delivery vehicles (troches, topical creams), or combinations with other agents such as tadalafil.

When Compounded Sildenafil Is Appropriate

Compounded sildenafil is not interchangeable with FDA-approved Viagra or generic sildenafil for formulary-coverage purposes. Appropriate clinical scenarios include:

• A patient requiring a strength not commercially available (e.g., 20 mg tablet for dose titration in elderly patients)
• Documented intolerance to commercial tablet excipients
• A prescriber-determined combination formulation under individualized clinical judgment

The FDA has published guidance clarifying that 503A pharmacies must compound based on a valid patient-specific prescription and may not compound commercially available strengths for routine substitution 10.

Finding a Licensed 503A Pharmacy in Maryland

The Maryland Board of Pharmacy maintains a searchable license database at pharmacy.maryland.gov. Look for the "Pharmacy, Compounding" designation. Maryland has multiple licensed 503A compounders in the Baltimore metro area, Montgomery County, and the Eastern Shore.

Safety: Contraindications and Drug Interactions

Sildenafil carries a small number of absolute contraindications that Maryland prescribers screen for during every qualifying visit.

Absolute Contraindications

• Organic nitrates (any route): Co-administration causes profound, potentially fatal hypotension. The interaction is pharmacodynamically additive on cGMP-mediated vasodilation 11. Nitrates include nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, and amyl nitrite ("poppers").
• Riociguat: Both agents lower systemic blood pressure via cGMP; combination is contraindicated per FDA labeling 3.
• Severe hepatic impairment (Child-Pugh C): Sildenafil clearance is markedly reduced, risking toxic accumulation 3.

Clinically Significant Interactions

• Alpha-blockers (tamsulosin, doxazosin): Additive hypotension. The FDA label recommends starting sildenafil at 25 mg when a patient is on a stable alpha-blocker regimen 3.
• Strong CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin): These agents increase sildenafil plasma AUC by up to 11-fold 12. Dose reduction to 25 mg per 48 hours is required with ritonavir.
• Grapefruit juice: A moderate CYP3A4 inhibitor; patients should avoid large quantities on dosing days.

Cardiovascular Risk Assessment

The Princeton Consensus Panel (Third Consensus Conference, 2012) stratified men with cardiovascular disease into low, intermediate, and high risk before PDE5 inhibitor initiation 13. Men in the low-risk category (controlled hypertension, asymptomatic with <3 CAD risk factors, NYHA Class I) may begin sildenafil without additional cardiac workup. Intermediate- or high-risk patients require cardiology input before prescribing.

Transferring an Existing Prescription to Maryland

If you hold a valid sildenafil prescription from another state and have relocated to Maryland, several options apply.

Retail Pharmacy Transfer

Any Maryland-licensed pharmacy may accept a prescription transfer from an out-of-state pharmacy for non-controlled substances. Sildenafil is unscheduled federally, so no special transfer documentation is required beyond the standard transfer request between pharmacies. Call the Maryland pharmacy directly with the name and phone number of your current pharmacy.

Telehealth Renewal in Maryland

If your original prescription was written by an out-of-state provider who is not licensed in Maryland, that provider cannot legally prescribe for you as a Maryland resident. A Maryland-licensed provider must issue a new prescription. A telehealth renewal visit typically takes under 15 minutes for an established patient with a documented history.

The American Urological Association confirms that continuity of PDE5 inhibitor therapy is the preferred clinical approach once a patient has an established, effective regimen 6, so documentation of prior response and tolerability speeds the renewal evaluation.

Common Side Effects and What to Tell Your Maryland Prescriber

Sildenafil's side-effect profile is well-characterized across decades of post-marketing data. In the NEJM 1998 trial, the most frequently reported adverse events were headache (16%), flushing (10%), dyspepsia (7%), and transient blue-green visual tinge (3%), all dose-related and transient 1.

When to Seek Emergency Care

• Chest pain during or after sexual activity: call 911 immediately. Do not take nitroglycerin if you have taken sildenafil within 24 hours 14.
• Sudden vision loss in one or both eyes: may indicate non-arteritic ischemic optic neuropathy (NAION), a rare but serious adverse event 15.
• Erection lasting more than four hours (priapism): requires emergency urological evaluation to prevent permanent tissue damage.

Reporting to Your Prescriber

Tell your Maryland prescriber at the follow-up visit (typically four to six weeks after initiation) whether:

• The 50 mg dose produced an adequate response
• Side effects affected tolerability
• You need a dose adjustment to 25 mg or 100 mg

The AUA recommends re-evaluating PDE5 inhibitor therapy at 3 months to assess satisfaction and safety 6.